Niaspan News
Most Popular Niaspan Story
Abbott results don't augur well for pharma spinoff
Abbott Laboratories ($ABT) is so far the only Big Pharma bucking the downward earnings trend. The company posted an increase in profits to $1.62 billion for the fourth quarter, on a 4.1% increase in Read more...
Latest Headlines
- January 25, 2012
- May 26, 2011
- November 25, 2009
- November 17, 2009
- November 16, 2009
- August 19, 2009
- July 20, 2009
- July 10, 2009
- July 9, 2009
- April 30, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
